Peachaphol Chongvoranond (2025) “Sodium-Glucose Cotransporter-2 inhibitor (SGLT2i) Prescription Rates Amongst Diabetologists for Type 2 Diabetes Patients with Albuminuric Diabetic Kidney Disease:: A Real-World Study at a Diabetes Center in Bangkok”, Journal of the ASEAN Federation of Endocrine Societies, 40(2), pp. 69–77. doi: 10.15605/jafes.040.02.22.